Associated Papers
The role of cytotoxic T-Lymphocyte antigen-4+49A/G gene polymorphism in cutaneous leishmaniasis.
Al-Ghabban MJS et al.
Microbial Pathogenesis, 2021
Comprehensive evaluation of the cytotoxic T-lymphocyte antigen-4 gene polymorphisms in risk of bone sarcoma.
Liu S et al.
Genetic Testing and Molecular Biomarkers, 2014
CD 152 gene polymorphisms and risk of osteosarcoma in Chinese population.
Chang Z et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2014
Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
Xiong YH et al.
International Immunopharmacology, 2014
Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.
Feng D et al.
Genetic Testing and Molecular Biomarkers, 2013
CD86 gene variants and susceptibility to pancreatic cancer.
Xiang H et al.
Journal of Cancer Research and Clinical Oncology, 2012
Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma.
Yang S et al.
Genetic Testing and Molecular Biomarkers, 2012
Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism and susceptibility to pancreatic cancer.
Lang C et al.
Dna and Cell Biology, 2012
Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y et al.
Dna and Cell Biology, 2011
Select a paper to view details